Fralick, M., Colacci, M., Odutayo, A., Siemieniuk, R., & Glynn, R
Topline Eli Lilly, the GLP-1 maker behind Mounjaro and Zepbound, said it would file for Food and Drug Administration approval of its powerful retatrutide weight-loss drug after studies found participants lost an average of nearly 56 pounds after 80 weeks on the medication
#wellnessjourney #healthtok #healthylifestyle 7 tips for beginners on a GLP-1 If youre new to GLP-1s, these are the tips I wish more people talked about
Take our quick quiz today
This is not a bug in retatrutide
These numbers suggest that some of the headaches could be related to other things rather than the medication, but many real-world users continue to report new or worsening headaches after starting semaglutide, so it is worth considering that the two may be related